Comparative study of two techniques of mycophenolate mofetyl monitoring
Jebabli, N.; Gaïes, E.; Charfi, R.; El Jebari, H.èn.; Ben Sassi, M.; Salouage, I.; Daghfous, R.; Trabelsi, S.
La Tunisie Medicale 97(8-9): 1010-1016
2019
ISSN/ISBN: 2724-7031 PMID: 32173850 Document Number: 699244
Mycophenolic acid (MPA) requires routine therapeutic drug monitoring. To evaluate the suitability of a MPA Immunoassay CEDIA performed on Indiko® analyzer (Thermo fisher) for monitoring of MPA by comparing values obtained by HPLC-UV method. This study was carried out on 114 blood samples collected from renal transplant, using high performance liquid chromatography combined with ultraviolet detection (HPLC-UV, reference method) and the new immunoassay on CEDIA. The assay was linear for a mycophenolic acid concentration up to 10 μg/mL. When MPA concentrations in all 114 transplant recipients obtained by the HPLC-UV (x-axis) method were compared with corresponding values obtained by the CEDIA® method (y-axis), the following regression equation was obtained: CEDIA® = 1.558 HPLC + 0.49 (r = 0.86). However more significant positive bias was observed (37 %). The data presented suggest that the CEDIA® MPA immunoassay, run on the Indiko® analyzer, over-estimates plasma MPA concentrations. However, CEDIA® immunoassay is less laborious and time consuming than chromatographia techniques.